Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the Gap Between Innovation and Capital


Amgen Ventures

Early stage biotech; pre-clinical therapeutic; diagnostic; medical device companies


Calling all early stage biotech; pre-clinical therapeutic; diagnostic; medical device and AI companies!

Amgen, the parent company of Amgen Ventures, has always appreciated the importance of funding early-stage innovation. Amgen was founded in 1980 by a small group of enterprising venture capitalists and scientists who saw the promise of emerging research in genetics. Since then, Amgen has grown to be a leading biotechnology company that has reached millions of patients with its medicines.

Since 2004, Amgen Ventures has invested in emerging companies to advance promising medicines and technologies supporting Amgen’s mission to treat patients with serious illnesses.


LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Amgen Ventures. Amgen seeks opportunities within oncology, immuno-oncology, cardiovascular, inflammation, bone health, nephrology, metabolic disorders, and neuroscience. Technologies include discovery research, digital health, health IT and drug delivery.

Applications will be selected based on meeting the following criteria:

Not restricted.

Company type:
Early-stage life science biotech companies developing therapeutics, medical devices or AI.

Milestones anticipated:

  • Areas of specific interest
    • CV/Metabolic:  peptide therapies, orals, for obesity, CKD, HF, PAH and atherosclerosis.
    • Inflammation:  IBD, Immune tolerance
    • Rare diseases:  gout, IPF
    • Oncology: radiopharmaceuticals
  • Platforms of interest =
    • Oral delivery of biologics
    • Novel mRNA manufacturing
    • High throughput cryo-EM enable/ AI/ML drug development platforms
  • Platform-focused therapeutic companies with disruptive technology.
  • Medical device companies addressing large unmet medical needs and markets with strong in vivo data, to fund design, manufacturing, and clinical testing

Companies seeking pre-seed, seed, and series A funding..


Qualifying start-ups can apply here today. Applications are accepted on a rolling basis.
Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.